TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: respiratory resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: dyspnea ratings
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Dysfunctional voiding detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: VE/VCO2 slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean aqueous humour concentration of Ciloxan and Siprogut
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean vitreous humour concentration of Ciloxan and Siprogut
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: net clinical adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Amphotericin-induced phlebitis
Endpoint domain: Adverse events/effects
Primary endpoint: Δz (tooth demineralization)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LD (lesion depth)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual perception
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: LV function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time induction-to-delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Need for oxytocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pathological CTG tracing
Endpoint domain: Adverse events/effects
Primary endpoint: Ki67+ proliferating CD4 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD4/CD8 ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cumulative survival percentages
Endpoint domain: Mortality/survival
Primary endpoint: hypotension prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in hyperactivity/impulsivity symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in oppositional and conduct disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inattention symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-procedural complication incidence
Endpoint domain: Adverse events/effects
Primary endpoint: intra-procedural complication incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Poor appetite
Endpoint domain: Adverse events/effects
Primary endpoint: Pulse increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of SE/IVH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Adherence to PD quality of care indicators
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Depressive symptomatology (Patient Health Questionnaire‐2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cortical blood flow (CBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of vocal cord injuries
Endpoint domain: Adverse events/effects
Primary endpoint: stone-free rate for multiple caliceal stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of bleeding necessitating transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: Occlusal relationship changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overjet reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical dimension of occlusion changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rates (no anxiety disorder)
Endpoint domain: Mortality/survival
Primary endpoint: Flinders Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sleep Self‐Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: ADHD Rating Scale‐IV scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ease of injections
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Induction of ISG15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum interferon‐α induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in pain and functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological, emotional and cognitive domains of trial participation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Balance and function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of interspinous space at L5/S1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition recovery (MMSE and MOCA scores)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Inflammatory markers (TNF‐α and IL‐6 levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: BDNF expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complete abortion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure rate of medical abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average duration of radiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of trials to position K-wire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Annual income reliability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean percent change from baseline FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: decrease in exacerbation days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Steady pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allodynia reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of sacroiliitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Emax Liking at the Moment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall Next Day Drug Liking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to Take the Drug Again
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion rates of examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cecal intubation times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of abdominal pressure
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular disease events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean group change scores (log WMFT, baseline to 12 months)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score (VAS, 0-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall and bone survival
Endpoint domain: Mortality/survival
Primary endpoint: Response rate on the Clinical Global Impression Scale for Anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in anxiety disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in parent-rated coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Episodes of fever and throat infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Upper respiratory tract infections episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Annual costs incurred
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall Survival Time
Endpoint domain: Mortality/survival
Primary endpoint: Confirmed Objective Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to symptomatic clinical stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptomatic change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pure-tone average (PTA) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of major cardiovascular events (MACE) at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: incidence of unstable angina with readmission at 4 years
Endpoint domain: Mortality/survival
Primary endpoint: primary treatment effect of 4 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preoperative anxiety levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache severity reduction at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Street sign legibility distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fixation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Driving speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean analgesic intake per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPD and death rates
Endpoint domain: Mortality/survival
Primary endpoint: HBsAg seroconversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SPPB scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean improvement in MADRS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tender joint count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma concentrations of vitamin E
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma concentrations of EPA, DHA and docosapentaenoic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fraction of body weight lost as fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visceral fat area decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: GDR increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver fat reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IMCL content decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: neutrophil to lymphocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Foot Functional Index total score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major amputations
Endpoint domain: Adverse events/effects
Primary endpoint: decrease in ulcer area ≥50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in inspiratory capacity (IC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIHSS score ≥ 20 at 7-10 days after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Worsening of NIHSS score >4 points at 7-10 days from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Success rate of allocated therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of noninvasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of desaturations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: maximum coronal knee angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: range of torsional knee angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: range of coronal plane knee moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incomplete healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Days using acute migraine medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: posterior extrusion of the medial meniscus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: QALY improvements
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total HAMD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kupperman score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep disorder
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Intensity of endometriosis-related pain symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation rate due to adverse effects
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Antibacterial activity against ESKAPE microorganisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Calcium and phosphate withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surface microhardness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical limitation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angina frequency scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular attack rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of VLBW neonates transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean deviation (MD) loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability levels (ODI scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity (VAS scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of second-trimester medical abortion
Endpoint domain: Mortality/survival
Primary endpoint: Doppler indices for the uterine arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: objective radiographic response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in GHQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in visit frequency
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Symptom improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in executive functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in logical memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: proportion of patients with severe endoscopic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: aggregate rates of severe recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mucosal inflammatory cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Spoken language development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROP (Retinopathy of Prematurity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NEC (Necrotizing Enterocolitis)
Endpoint domain: Adverse events/effects
Primary endpoint: CSP reduction after caffeine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: C-peptide measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: NK and T helper cell infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Resolution of lactic acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nodal recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Total clearing of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: panic frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: avoidance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Anxiety management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feeling adequately informed about PC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recalled being offered various support options
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Rated care as good/excellent
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Need for analgesia with pethidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative doses of pethidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative doses of tramadol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative doses of metamizole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: meditative state measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: defecation frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of tricuspid regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Resting ANP secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Remission rate (Hamilton Anxiety Rating Scale score < 7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline capillary density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative survival probability at 72 months
Endpoint domain: Mortality/survival
Primary endpoint: postural score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure remission status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Need for after-trial plausibility checks of anthropometric data
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cessation of tobacco use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensitivity and specificity of tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Total accuracy of tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Early Bactericidal Activity (EBA) of INH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with HIV-1 RNA less than 50 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effectiveness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate cancer risk associated with STIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gingival crevicular fluid LDH activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total serum triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VLDL and LDL triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LDL-triglyceride/apo B ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Local failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cause-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: Composite endpoint of cardiovascular death, myocardial infarction, or stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes